Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Papio | 59 | 2020 | 91 | 6.470 |
Why?
|
Liver | 15 | 2018 | 483 | 2.180 |
Why?
|
Animals | 97 | 2020 | 7466 | 2.170 |
Why?
|
Gene Expression Profiling | 15 | 2013 | 323 | 1.870 |
Why?
|
Maternal Nutritional Physiological Phenomena | 10 | 2018 | 16 | 1.820 |
Why?
|
Quantitative Trait Loci | 20 | 2015 | 140 | 1.820 |
Why?
|
Kidney | 10 | 2018 | 515 | 1.740 |
Why?
|
Fetus | 9 | 2018 | 86 | 1.730 |
Why?
|
Cholesterol, LDL | 9 | 2019 | 173 | 1.730 |
Why?
|
Papio hamadryas | 12 | 2019 | 15 | 1.630 |
Why?
|
Atherosclerosis | 8 | 2019 | 767 | 1.610 |
Why?
|
Gene Expression Regulation | 8 | 2020 | 494 | 1.490 |
Why?
|
MicroRNAs | 5 | 2019 | 180 | 1.440 |
Why?
|
Cholesterol, Dietary | 6 | 2019 | 36 | 1.210 |
Why?
|
Gene Expression Regulation, Developmental | 12 | 2019 | 69 | 1.200 |
Why?
|
Cholesterol, HDL | 5 | 2012 | 177 | 1.090 |
Why?
|
Pregnancy | 21 | 2019 | 994 | 1.090 |
Why?
|
Metabolomics | 3 | 2019 | 54 | 0.990 |
Why?
|
Genomics | 5 | 2019 | 84 | 0.980 |
Why?
|
Genetic Variation | 14 | 2019 | 245 | 0.950 |
Why?
|
Hypertension | 6 | 2017 | 957 | 0.930 |
Why?
|
Disease Models, Animal | 12 | 2020 | 1017 | 0.920 |
Why?
|
Fetal Growth Retardation | 4 | 2019 | 34 | 0.890 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 104 | 0.890 |
Why?
|
Proteomics | 3 | 2019 | 94 | 0.880 |
Why?
|
Obesity | 7 | 2018 | 1179 | 0.870 |
Why?
|
Fetal Development | 4 | 2018 | 25 | 0.860 |
Why?
|
Lipase | 4 | 2011 | 28 | 0.860 |
Why?
|
Iliac Artery | 2 | 2019 | 49 | 0.850 |
Why?
|
Endothelium, Vascular | 3 | 2015 | 156 | 0.820 |
Why?
|
Genome | 7 | 2012 | 38 | 0.820 |
Why?
|
Cholesterol | 4 | 2019 | 251 | 0.800 |
Why?
|
Diet | 6 | 2019 | 386 | 0.800 |
Why?
|
Dietary Fats | 4 | 2019 | 111 | 0.770 |
Why?
|
RNA, Messenger | 15 | 2018 | 508 | 0.770 |
Why?
|
Female | 58 | 2020 | 19953 | 0.740 |
Why?
|
Antiporters | 3 | 2017 | 9 | 0.710 |
Why?
|
Leukocytes, Mononuclear | 3 | 2019 | 56 | 0.700 |
Why?
|
Cardiovascular Diseases | 5 | 2017 | 1125 | 0.690 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 208 | 0.690 |
Why?
|
Leukocytes | 2 | 2019 | 59 | 0.690 |
Why?
|
Phylogeny | 7 | 2019 | 55 | 0.680 |
Why?
|
Phenotype | 17 | 2018 | 639 | 0.680 |
Why?
|
Papio anubis | 5 | 2019 | 8 | 0.650 |
Why?
|
Male | 45 | 2020 | 19195 | 0.640 |
Why?
|
Gas Chromatography-Mass Spectrometry | 4 | 2019 | 28 | 0.640 |
Why?
|
Chromosome Mapping | 12 | 2015 | 193 | 0.640 |
Why?
|
Breath Tests | 1 | 2018 | 15 | 0.630 |
Why?
|
Molecular Sequence Data | 16 | 2011 | 356 | 0.630 |
Why?
|
Volatile Organic Compounds | 1 | 2018 | 7 | 0.630 |
Why?
|
DNA Methylation | 2 | 2009 | 140 | 0.630 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 29 | 0.620 |
Why?
|
Animal Nutritional Physiological Phenomena | 5 | 2017 | 9 | 0.620 |
Why?
|
Papio cynocephalus | 5 | 2019 | 6 | 0.610 |
Why?
|
Cardiovascular System | 1 | 2018 | 42 | 0.610 |
Why?
|
Malnutrition | 3 | 2018 | 17 | 0.600 |
Why?
|
Primates | 3 | 2017 | 104 | 0.600 |
Why?
|
Amino Acid Sequence | 16 | 2011 | 283 | 0.580 |
Why?
|
Sodium, Dietary | 1 | 2017 | 23 | 0.570 |
Why?
|
Computational Biology | 3 | 2019 | 91 | 0.550 |
Why?
|
Placenta | 3 | 2013 | 74 | 0.530 |
Why?
|
Proteome | 2 | 2006 | 39 | 0.530 |
Why?
|
Pregnancy, Animal | 2 | 2013 | 19 | 0.520 |
Why?
|
Humans | 49 | 2020 | 32024 | 0.520 |
Why?
|
Carboxylesterase | 3 | 2010 | 3 | 0.520 |
Why?
|
Angiotensin II | 1 | 2017 | 243 | 0.510 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 178 | 0.510 |
Why?
|
Proteoglycans | 1 | 2015 | 32 | 0.500 |
Why?
|
Blood Pressure | 3 | 2017 | 845 | 0.500 |
Why?
|
Sequence Alignment | 9 | 2012 | 60 | 0.500 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2012 | 161 | 0.480 |
Why?
|
Pedigree | 13 | 2020 | 140 | 0.470 |
Why?
|
Inflammation | 3 | 2015 | 540 | 0.470 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 148 | 0.470 |
Why?
|
Endothelial Cells | 3 | 2012 | 189 | 0.460 |
Why?
|
Sepsis | 1 | 2015 | 158 | 0.450 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2016 | 1067 | 0.430 |
Why?
|
Genotype | 14 | 2019 | 734 | 0.430 |
Why?
|
Fetal Heart | 1 | 2012 | 5 | 0.420 |
Why?
|
Chromosomes, Mammalian | 4 | 2009 | 13 | 0.390 |
Why?
|
Lipoprotein Lipase | 1 | 2011 | 14 | 0.390 |
Why?
|
Vertebrates | 1 | 2011 | 2 | 0.380 |
Why?
|
Lipoproteins, VLDL | 1 | 2011 | 27 | 0.380 |
Why?
|
Base Sequence | 10 | 2019 | 251 | 0.370 |
Why?
|
Serum | 3 | 2019 | 19 | 0.370 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2018 | 90 | 0.360 |
Why?
|
Food Deprivation | 2 | 2007 | 3 | 0.360 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 1 | 0.360 |
Why?
|
Gestational Age | 5 | 2015 | 120 | 0.360 |
Why?
|
Lymphocytes | 1 | 2010 | 57 | 0.360 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 10 | 2013 | 261 | 0.350 |
Why?
|
Appetite | 1 | 2009 | 22 | 0.340 |
Why?
|
Genetic Techniques | 1 | 2009 | 7 | 0.340 |
Why?
|
Lipid Metabolism | 4 | 2018 | 104 | 0.340 |
Why?
|
Rats | 8 | 2018 | 1596 | 0.330 |
Why?
|
Species Specificity | 9 | 2020 | 89 | 0.330 |
Why?
|
Principal Component Analysis | 2 | 2019 | 68 | 0.320 |
Why?
|
Protein Structure, Tertiary | 5 | 2011 | 99 | 0.320 |
Why?
|
Transcription Factors | 1 | 2009 | 180 | 0.320 |
Why?
|
Aging | 4 | 2019 | 945 | 0.300 |
Why?
|
Lipids | 3 | 2018 | 229 | 0.300 |
Why?
|
Hominidae | 2 | 2020 | 3 | 0.300 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2007 | 5 | 0.290 |
Why?
|
Embryonic Development | 1 | 2007 | 7 | 0.290 |
Why?
|
Chromosomes | 2 | 2006 | 9 | 0.290 |
Why?
|
Models, Animal | 8 | 2016 | 164 | 0.290 |
Why?
|
Protein Kinases | 1 | 2006 | 26 | 0.280 |
Why?
|
Exons | 4 | 2011 | 52 | 0.280 |
Why?
|
Sequence Analysis, DNA | 5 | 2012 | 137 | 0.270 |
Why?
|
Macaca mulatta | 3 | 2016 | 285 | 0.260 |
Why?
|
Models, Genetic | 5 | 2020 | 94 | 0.260 |
Why?
|
Transcription, Genetic | 4 | 2011 | 137 | 0.260 |
Why?
|
Reproducibility of Results | 5 | 2015 | 765 | 0.260 |
Why?
|
Signal Transduction | 5 | 2020 | 687 | 0.260 |
Why?
|
Genes | 4 | 2010 | 15 | 0.250 |
Why?
|
Aorta | 2 | 2019 | 125 | 0.250 |
Why?
|
Sex Factors | 5 | 2020 | 663 | 0.250 |
Why?
|
Heart | 3 | 2013 | 179 | 0.240 |
Why?
|
Cattle | 4 | 2012 | 103 | 0.240 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2011 | 70 | 0.230 |
Why?
|
DNA, Complementary | 5 | 2009 | 30 | 0.230 |
Why?
|
Nutritional Status | 2 | 2017 | 75 | 0.220 |
Why?
|
Protein Structure, Secondary | 4 | 2011 | 47 | 0.220 |
Why?
|
RNA, Untranslated | 2 | 2013 | 10 | 0.210 |
Why?
|
Blood Glucose | 2 | 2020 | 492 | 0.210 |
Why?
|
Brain | 5 | 2015 | 950 | 0.210 |
Why?
|
Polymorphism, Genetic | 4 | 2019 | 184 | 0.210 |
Why?
|
Adenosine Triphosphatases | 1 | 2002 | 13 | 0.200 |
Why?
|
Immunohistochemistry | 4 | 2013 | 532 | 0.200 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 109 | 0.200 |
Why?
|
Models, Molecular | 3 | 2011 | 193 | 0.200 |
Why?
|
Mice | 9 | 2016 | 2475 | 0.200 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2018 | 19 | 0.200 |
Why?
|
Caloric Restriction | 2 | 2017 | 106 | 0.200 |
Why?
|
Hydrocortisone | 2 | 2018 | 57 | 0.200 |
Why?
|
Quantitative Trait, Heritable | 7 | 2005 | 47 | 0.200 |
Why?
|
Trophoblasts | 2 | 2019 | 10 | 0.190 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 45 | 0.180 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 18 | 0.180 |
Why?
|
Surface Plasmon Resonance | 1 | 2020 | 7 | 0.180 |
Why?
|
Dengue | 1 | 2020 | 5 | 0.180 |
Why?
|
Reproduction | 1 | 2020 | 12 | 0.180 |
Why?
|
Quadriceps Muscle | 1 | 2020 | 34 | 0.180 |
Why?
|
Aorta, Thoracic | 2 | 2019 | 85 | 0.180 |
Why?
|
Hybridization, Genetic | 2 | 2019 | 3 | 0.180 |
Why?
|
DNA Primers | 3 | 2010 | 90 | 0.180 |
Why?
|
Spermatozoa | 1 | 2020 | 28 | 0.180 |
Why?
|
Biosensing Techniques | 1 | 2020 | 25 | 0.180 |
Why?
|
Prediabetic State | 1 | 2020 | 65 | 0.180 |
Why?
|
Gene Duplication | 2 | 2011 | 5 | 0.180 |
Why?
|
Asparagine | 1 | 2019 | 6 | 0.170 |
Why?
|
Alternative Splicing | 2 | 1999 | 30 | 0.170 |
Why?
|
Organ Specificity | 3 | 2018 | 80 | 0.170 |
Why?
|
Placental Insufficiency | 1 | 2019 | 1 | 0.170 |
Why?
|
Lactic Acid | 1 | 2019 | 53 | 0.160 |
Why?
|
Extracellular Matrix | 1 | 2020 | 245 | 0.160 |
Why?
|
Adipocytes | 2 | 2010 | 80 | 0.160 |
Why?
|
Exhalation | 1 | 2018 | 3 | 0.160 |
Why?
|
Sequence Deletion | 1 | 1998 | 40 | 0.160 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 19 | 0.160 |
Why?
|
Kidney Cortex | 1 | 2018 | 25 | 0.160 |
Why?
|
Kidney Medulla | 1 | 2018 | 29 | 0.160 |
Why?
|
Lipoprotein(a) | 1 | 1998 | 21 | 0.160 |
Why?
|
Metabolome | 1 | 2018 | 36 | 0.160 |
Why?
|
Birth Weight | 1 | 2018 | 47 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 4 | 2011 | 835 | 0.150 |
Why?
|
Lod Score | 5 | 2009 | 72 | 0.150 |
Why?
|
Chagas Disease | 1 | 2017 | 7 | 0.150 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2008 | 9 | 0.150 |
Why?
|
Risk Factors | 6 | 2019 | 3869 | 0.150 |
Why?
|
Diet, Atherogenic | 2 | 2017 | 61 | 0.150 |
Why?
|
Gene Order | 2 | 2011 | 6 | 0.150 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 47 | 0.150 |
Why?
|
Reference Standards | 2 | 2017 | 32 | 0.150 |
Why?
|
Monkey Diseases | 1 | 2017 | 16 | 0.150 |
Why?
|
Databases, Genetic | 2 | 2017 | 37 | 0.150 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2015 | 41 | 0.150 |
Why?
|
Mass Spectrometry | 1 | 2017 | 103 | 0.150 |
Why?
|
Mitochondria | 2 | 2019 | 186 | 0.150 |
Why?
|
Glucose | 1 | 2018 | 174 | 0.150 |
Why?
|
Cell Differentiation | 3 | 2016 | 468 | 0.140 |
Why?
|
Forearm | 2 | 2015 | 43 | 0.140 |
Why?
|
Osteocalcin | 2 | 2006 | 9 | 0.140 |
Why?
|
Myeloid Cells | 1 | 2016 | 39 | 0.140 |
Why?
|
Insulin | 1 | 2018 | 366 | 0.140 |
Why?
|
Caspase 3 | 2 | 2013 | 31 | 0.140 |
Why?
|
Apolipoproteins | 1 | 1998 | 200 | 0.140 |
Why?
|
Antigens, CD | 1 | 2016 | 103 | 0.130 |
Why?
|
Tissue Distribution | 2 | 2006 | 60 | 0.130 |
Why?
|
Multigene Family | 3 | 2010 | 51 | 0.130 |
Why?
|
Protein Isoforms | 2 | 2013 | 57 | 0.130 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 121 | 0.130 |
Why?
|
Gene Expression | 3 | 2013 | 335 | 0.130 |
Why?
|
Nitroprusside | 1 | 2015 | 5 | 0.130 |
Why?
|
Genes, Mitochondrial | 1 | 2015 | 2 | 0.130 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 17 | 0.130 |
Why?
|
Nitroglycerin | 1 | 2015 | 11 | 0.130 |
Why?
|
Endotoxemia | 1 | 2015 | 7 | 0.130 |
Why?
|
Blotting, Western | 2 | 2013 | 292 | 0.130 |
Why?
|
Personality | 1 | 2015 | 16 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2006 | 19 | 0.120 |
Why?
|
Blood Flow Velocity | 1 | 2015 | 76 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2015 | 61 | 0.120 |
Why?
|
Organ Size | 3 | 2009 | 210 | 0.120 |
Why?
|
Vasodilation | 1 | 2015 | 93 | 0.120 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 594 | 0.120 |
Why?
|
Erythrocytes | 2 | 2013 | 48 | 0.120 |
Why?
|
Cloning, Molecular | 4 | 2009 | 75 | 0.120 |
Why?
|
Lipoproteins | 2 | 2017 | 84 | 0.120 |
Why?
|
Cerebral Cortex | 1 | 2015 | 125 | 0.120 |
Why?
|
Young Adult | 3 | 2019 | 2615 | 0.120 |
Why?
|
Dogs | 2 | 2011 | 120 | 0.120 |
Why?
|
bcl-2-Associated X Protein | 1 | 2013 | 14 | 0.110 |
Why?
|
Genes, Tumor Suppressor | 1 | 1994 | 34 | 0.110 |
Why?
|
Adipose Tissue | 3 | 2008 | 347 | 0.110 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 197 | 0.110 |
Why?
|
INDEL Mutation | 1 | 2013 | 11 | 0.110 |
Why?
|
Callithrix | 1 | 2013 | 2 | 0.110 |
Why?
|
Chlorophyll | 1 | 2013 | 2 | 0.110 |
Why?
|
Phytanic Acid | 1 | 2013 | 4 | 0.110 |
Why?
|
Diet, Vegetarian | 1 | 2013 | 3 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2015 | 250 | 0.110 |
Why?
|
Research Design | 1 | 2015 | 312 | 0.110 |
Why?
|
Metagenome | 1 | 2012 | 5 | 0.110 |
Why?
|
Mothers | 1 | 2013 | 88 | 0.110 |
Why?
|
Neoplasms | 1 | 2019 | 692 | 0.110 |
Why?
|
Body Weight | 3 | 2012 | 310 | 0.100 |
Why?
|
Pregnancy, Multiple | 1 | 2012 | 10 | 0.100 |
Why?
|
Sheep, Domestic | 1 | 2012 | 18 | 0.100 |
Why?
|
Femoral Artery | 1 | 2012 | 50 | 0.100 |
Why?
|
Myocardium | 1 | 2013 | 186 | 0.100 |
Why?
|
Desoxycorticosterone | 1 | 2012 | 1 | 0.100 |
Why?
|
Annexin A1 | 1 | 2012 | 1 | 0.100 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2012 | 2 | 0.100 |
Why?
|
Colon | 1 | 2012 | 52 | 0.100 |
Why?
|
Glutathione Transferase | 1 | 2012 | 13 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 1428 | 0.100 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1990 | 10 | 0.100 |
Why?
|
DNA | 3 | 2009 | 228 | 0.100 |
Why?
|
Th2 Cells | 1 | 2011 | 10 | 0.100 |
Why?
|
Genes, Homeobox | 1 | 2011 | 4 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 4 | 2010 | 18 | 0.100 |
Why?
|
Bone Density | 3 | 2012 | 203 | 0.100 |
Why?
|
Alleles | 3 | 2019 | 248 | 0.100 |
Why?
|
Th1 Cells | 1 | 2011 | 26 | 0.100 |
Why?
|
Biopsy | 1 | 2012 | 260 | 0.100 |
Why?
|
Guinea Pigs | 1 | 2011 | 11 | 0.100 |
Why?
|
Cell Survival | 2 | 2011 | 286 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 51 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2011 | 20 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2011 | 14 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2011 | 49 | 0.090 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2010 | 7 | 0.090 |
Why?
|
Superoxide Dismutase | 1 | 2011 | 46 | 0.090 |
Why?
|
Pseudogenes | 1 | 2010 | 5 | 0.090 |
Why?
|
Adiposity | 1 | 2012 | 199 | 0.090 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2010 | 25 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 1 | 2010 | 6 | 0.090 |
Why?
|
Motor Neurons | 1 | 2011 | 56 | 0.090 |
Why?
|
Terminology as Topic | 1 | 2010 | 64 | 0.090 |
Why?
|
Aspartate Aminotransferases | 1 | 2010 | 29 | 0.090 |
Why?
|
Cell Size | 1 | 2010 | 38 | 0.090 |
Why?
|
Methylation | 1 | 2010 | 5 | 0.090 |
Why?
|
Pancreas | 1 | 2011 | 104 | 0.090 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2011 | 72 | 0.090 |
Why?
|
gamma-Glutamyltransferase | 1 | 2009 | 11 | 0.090 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1990 | 38 | 0.090 |
Why?
|
Genetic Markers | 3 | 2009 | 124 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 324 | 0.090 |
Why?
|
Stem Cells | 1 | 2012 | 313 | 0.090 |
Why?
|
Somatomedins | 1 | 2009 | 5 | 0.090 |
Why?
|
Time Factors | 1 | 2015 | 2152 | 0.090 |
Why?
|
Serum Albumin | 1 | 2009 | 54 | 0.090 |
Why?
|
Adult | 4 | 2019 | 9366 | 0.090 |
Why?
|
Body Composition | 2 | 2012 | 396 | 0.080 |
Why?
|
Environment | 2 | 2007 | 54 | 0.080 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2009 | 10 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2009 | 40 | 0.080 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2009 | 1 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 57 | 0.080 |
Why?
|
Protein Subunits | 1 | 2009 | 34 | 0.080 |
Why?
|
Animals, Newborn | 2 | 2018 | 115 | 0.080 |
Why?
|
Opossums | 1 | 2008 | 2 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2009 | 105 | 0.080 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2008 | 3 | 0.080 |
Why?
|
Ghrelin | 1 | 2008 | 2 | 0.080 |
Why?
|
Skull | 1 | 2008 | 48 | 0.080 |
Why?
|
Gene Flow | 2 | 2019 | 2 | 0.080 |
Why?
|
Lipoproteins, HDL | 3 | 2005 | 251 | 0.070 |
Why?
|
Adiponectin | 1 | 2008 | 106 | 0.070 |
Why?
|
Blood Cell Count | 1 | 2007 | 28 | 0.070 |
Why?
|
Receptors, Prostaglandin E | 1 | 2007 | 4 | 0.070 |
Why?
|
Retinoblastoma Protein | 2 | 1999 | 10 | 0.070 |
Why?
|
Breast Neoplasms | 1 | 1994 | 761 | 0.070 |
Why?
|
Animal Feed | 1 | 2006 | 16 | 0.070 |
Why?
|
Bone Remodeling | 1 | 2006 | 9 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 38 | 0.070 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 41 | 0.070 |
Why?
|
Osteoblasts | 1 | 2006 | 45 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2008 | 148 | 0.070 |
Why?
|
Apolipoproteins E | 2 | 2002 | 94 | 0.070 |
Why?
|
Betamethasone | 1 | 2007 | 53 | 0.070 |
Why?
|
Fetal Nutrition Disorders | 1 | 2006 | 1 | 0.070 |
Why?
|
Cell Cycle | 3 | 1999 | 77 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2006 | 111 | 0.070 |
Why?
|
Bone and Bones | 1 | 2006 | 94 | 0.070 |
Why?
|
Hypertension, Renal | 1 | 2006 | 29 | 0.070 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2005 | 15 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2007 | 148 | 0.070 |
Why?
|
Cell Proliferation | 3 | 2013 | 599 | 0.060 |
Why?
|
Hormones, Ectopic | 1 | 2005 | 1 | 0.060 |
Why?
|
Aryldialkylphosphatase | 1 | 2005 | 5 | 0.060 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2005 | 24 | 0.060 |
Why?
|
Omentum | 1 | 2005 | 26 | 0.060 |
Why?
|
Lung | 1 | 2007 | 255 | 0.060 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 8 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2004 | 59 | 0.060 |
Why?
|
Likelihood Functions | 3 | 2016 | 48 | 0.060 |
Why?
|
Haplotypes | 2 | 2019 | 220 | 0.060 |
Why?
|
Cluster Analysis | 2 | 2015 | 128 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 1194 | 0.060 |
Why?
|
Evolution, Molecular | 2 | 2016 | 34 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 1 | 2002 | 19 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 411 | 0.050 |
Why?
|
Monocytes | 2 | 2016 | 126 | 0.050 |
Why?
|
Genome, Human | 1 | 2002 | 132 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 766 | 0.050 |
Why?
|
Macrophages | 2 | 2016 | 192 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2002 | 132 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2002 | 122 | 0.050 |
Why?
|
Sodium | 1 | 2001 | 39 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2020 | 10 | 0.050 |
Why?
|
Brazil | 1 | 2020 | 16 | 0.050 |
Why?
|
Viral Envelope Proteins | 1 | 2020 | 10 | 0.050 |
Why?
|
Gold | 1 | 2020 | 18 | 0.050 |
Why?
|
Cell Division | 1 | 2020 | 95 | 0.050 |
Why?
|
Fibrosis | 1 | 2020 | 118 | 0.050 |
Why?
|
Metal Nanoparticles | 1 | 2020 | 16 | 0.040 |
Why?
|
Introns | 2 | 1998 | 39 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2020 | 58 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 47 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2015 | 687 | 0.040 |
Why?
|
Inbreeding | 1 | 2019 | 5 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2019 | 22 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1999 | 12 | 0.040 |
Why?
|
Electron Transport | 1 | 2019 | 16 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 23 | 0.040 |
Why?
|
Isoenzymes | 2 | 2010 | 61 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 73 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 80 | 0.040 |
Why?
|
RNA Interference | 1 | 2019 | 76 | 0.040 |
Why?
|
Plasminogen | 1 | 1998 | 1 | 0.040 |
Why?
|
Apoprotein(a) | 1 | 1998 | 1 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2018 | 79 | 0.040 |
Why?
|
Cloning, Organism | 1 | 1998 | 12 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 1999 | 120 | 0.040 |
Why?
|
Skinfold Thickness | 1 | 2018 | 7 | 0.040 |
Why?
|
Pericardium | 1 | 2018 | 52 | 0.040 |
Why?
|
Lactation | 1 | 2017 | 15 | 0.040 |
Why?
|
Membrane Proteins | 1 | 1999 | 257 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 91 | 0.040 |
Why?
|
Arteries | 1 | 2017 | 67 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2016 | 2 | 0.040 |
Why?
|
Population Density | 1 | 2016 | 8 | 0.040 |
Why?
|
Chemokine CX3CL1 | 1 | 2016 | 4 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2018 | 171 | 0.040 |
Why?
|
Lectins | 1 | 2016 | 10 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2016 | 51 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2019 | 833 | 0.030 |
Why?
|
Microvessels | 1 | 2016 | 25 | 0.030 |
Why?
|
Apolipoproteins B | 2 | 2002 | 46 | 0.030 |
Why?
|
Kenya | 1 | 2016 | 11 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 65 | 0.030 |
Why?
|
Acetaminophen | 1 | 2016 | 19 | 0.030 |
Why?
|
Genetics, Population | 1 | 2016 | 32 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2016 | 60 | 0.030 |
Why?
|
Cohort Studies | 1 | 2020 | 1831 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2015 | 6 | 0.030 |
Why?
|
Homovanillic Acid | 1 | 2015 | 11 | 0.030 |
Why?
|
Synaptosomal-Associated Protein 25 | 1 | 2015 | 6 | 0.030 |
Why?
|
Phenols | 1 | 2015 | 17 | 0.030 |
Why?
|
Incidence | 1 | 2018 | 1200 | 0.030 |
Why?
|
Cytokines | 1 | 2016 | 260 | 0.030 |
Why?
|
Social Behavior | 1 | 2015 | 65 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1994 | 55 | 0.030 |
Why?
|
Racemases and Epimerases | 1 | 2013 | 4 | 0.030 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2013 | 9 | 0.030 |
Why?
|
Mixed Function Oxygenases | 1 | 2013 | 12 | 0.030 |
Why?
|
Oxidoreductases | 1 | 2013 | 26 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2011 | 4000 | 0.030 |
Why?
|
Gastric Inhibitory Polypeptide | 1 | 2012 | 1 | 0.030 |
Why?
|
Weaning | 1 | 2012 | 7 | 0.030 |
Why?
|
Bone Development | 1 | 2012 | 8 | 0.030 |
Why?
|
Cecum | 1 | 2012 | 9 | 0.030 |
Why?
|
Fatty Acids, Volatile | 1 | 2012 | 9 | 0.030 |
Why?
|
Feces | 1 | 2012 | 40 | 0.030 |
Why?
|
Ligation | 1 | 2012 | 56 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2012 | 57 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2012 | 81 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2012 | 186 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2013 | 137 | 0.030 |
Why?
|
Ischemia | 1 | 2012 | 98 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 110 | 0.030 |
Why?
|
Heredity | 1 | 2011 | 13 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2011 | 29 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 2011 | 2 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 8 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 18 | 0.020 |
Why?
|
Lentivirus | 1 | 2011 | 11 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2011 | 146 | 0.020 |
Why?
|
Sequence Homology | 1 | 2010 | 3 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 41 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 77 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2011 | 37 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2011 | 72 | 0.020 |
Why?
|
Pongo | 1 | 2010 | 1 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2010 | 7 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2011 | 83 | 0.020 |
Why?
|
Horses | 1 | 2010 | 13 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2011 | 120 | 0.020 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1990 | 4 | 0.020 |
Why?
|
Genes, Dominant | 1 | 1990 | 27 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 174 | 0.020 |
Why?
|
Crown-Rump Length | 1 | 2009 | 1 | 0.020 |
Why?
|
Amino Acid Transport System A | 1 | 2009 | 1 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2009 | 12 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2009 | 6 | 0.020 |
Why?
|
Receptor, IGF Type 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
Liver Glycogen | 1 | 2009 | 4 | 0.020 |
Why?
|
Chorionic Villi | 1 | 2009 | 7 | 0.020 |
Why?
|
E-Selectin | 1 | 2009 | 20 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
Placentation | 1 | 2009 | 4 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2009 | 7 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 27 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 20 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2009 | 26 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 227 | 0.020 |
Why?
|
Receptors, LDL | 1 | 1989 | 65 | 0.020 |
Why?
|
Leptin | 1 | 2009 | 71 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2009 | 48 | 0.020 |
Why?
|
Amino Acids | 1 | 2009 | 47 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 70 | 0.020 |
Why?
|
Fetal Blood | 1 | 2009 | 38 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2009 | 10 | 0.020 |
Why?
|
NF-kappa B | 1 | 2009 | 81 | 0.020 |
Why?
|
Apolipoproteins A | 1 | 1988 | 25 | 0.020 |
Why?
|
Amniotic Fluid | 1 | 2009 | 86 | 0.020 |
Why?
|
Apolipoproteins C | 1 | 1988 | 4 | 0.020 |
Why?
|
Anthropometry | 1 | 2008 | 83 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 211 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 488 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 109 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2008 | 18 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2008 | 87 | 0.020 |
Why?
|
Intestines | 1 | 2008 | 64 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 3 | 0.020 |
Why?
|
Aged | 2 | 2011 | 10340 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 1269 | 0.020 |
Why?
|
Central Nervous System | 2 | 1999 | 43 | 0.020 |
Why?
|
Middle Aged | 2 | 2011 | 11868 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2006 | 11 | 0.020 |
Why?
|
Models, Biological | 1 | 2008 | 391 | 0.020 |
Why?
|
Resistin | 1 | 2005 | 4 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 1435 | 0.020 |
Why?
|
Glucose Transporter Type 4 | 1 | 2004 | 9 | 0.020 |
Why?
|
Child | 1 | 2011 | 2441 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2006 | 673 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2002 | 13 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 3526 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 108 | 0.010 |
Why?
|
Genes, Regulator | 1 | 2002 | 5 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 11 | 0.010 |
Why?
|
Particle Size | 1 | 2002 | 46 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2002 | 21 | 0.010 |
Why?
|
Lithium | 1 | 2001 | 5 | 0.010 |
Why?
|
Restriction Mapping | 2 | 1989 | 14 | 0.010 |
Why?
|
Blotting, Southern | 2 | 1989 | 24 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1999 | 15 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 1999 | 21 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1999 | 38 | 0.010 |
Why?
|
Mice, Knockout | 1 | 1999 | 444 | 0.010 |
Why?
|
Genes, Retinoblastoma | 1 | 1994 | 2 | 0.010 |
Why?
|
DNA Probes | 1 | 1994 | 19 | 0.010 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 1994 | 3 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1994 | 16 | 0.010 |
Why?
|
Gene Deletion | 1 | 1994 | 66 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 1994 | 78 | 0.010 |
Why?
|
Apoptosis | 1 | 1994 | 354 | 0.010 |
Why?
|
Immunoblotting | 1 | 1988 | 51 | 0.010 |
Why?
|
Apolipoprotein A-I | 1 | 1988 | 68 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1989 | 464 | 0.000 |
Why?
|
Apolipoprotein C-I | 1 | 1988 | 4 | 0.000 |
Why?
|
Macaca fascicularis | 1 | 1988 | 397 | 0.000 |
Why?
|